Semaglutide
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Novo Nordisk · Phase 3 · Completed · Enrollment 150
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide 2.4 mg | Obesity or overweight | 2.4 mg | 50 | ITT | n/r |
| Placebo | Obesity or overweight | n/r | 50 | ITT | n/r |
| Semaglutide, on treatment | Obesity or overweight | n/r | 44 | Efficacy | n/r |
| Placebo, on treatment | Obesity or overweight | n/r | 44 | Efficacy | n/r |